REQUEST A DEMO
Total
USD $0.00
Search more companies

Xepa-Soul Pattinson (Malaysia) Sdn Bhd (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Xepa-Soul Pattinson (Malaysia) Sdn Bhd Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

xepa sp is a pharmaceutical company offering medicines and seeking distribution partners worldwide. They also provide on-the-job experience for students.

Headquarters
1-5, Jalan Ttc 1, Cheng Industrial Estate
Melaka; Malacca; Postal Code: 75250

Contact Details: Purchase the Xepa-Soul Pattinson (Malaysia) Sdn Bhd report to view the information.

Website: http://www.xepasp.com

Basic Information
Total Employees:
Purchase the Xepa-Soul Pattinson (Malaysia) Sdn Bhd report to view the information.
Outstanding Shares:
Purchase the Xepa-Soul Pattinson (Malaysia) Sdn Bhd report to view the information.
Registered Capital:
Purchase the Xepa-Soul Pattinson (Malaysia) Sdn Bhd report to view the information.
Financial Auditors:
Purchase the Xepa-Soul Pattinson (Malaysia) Sdn Bhd report to view the information.
Incorporation Date:
August 18, 1969
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Xepa-Soul Pattinson (Malaysia) Sdn Bhd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
12.54%
Total operating revenue
12.54%
Operating profit (EBIT)
16.46%
EBITDA
-5.44%
Net Profit (Loss) for the Period
10.5%
Total assets
6.77%
Total equity
3.59%
Operating Profit Margin (ROS)
0.87%
Net Profit Margin
-0.37%
Return on Equity (ROE)
1.79%
Debt to Equity Ratio
-3.46%
Quick Ratio
-0.11%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?